Podcasts about new guidelines

Are you up to date with the latest guidelines on deep venous thrombosis (DVT) management? Dr. Steven Abramowitz, vascular surgeon at MedStar Health, joins host Dr. Chris Beck for a deep dive into emerging clinical data in DVT management, where they review the evolving indications for mechanical thrombectomy and the implications of studies like the ATTRACT trial, the CLOUT registry, and the ongoing DEFIANCE trial. --- This podcast is supported by: Inari Medicalhttps://www.inarimedical.com/artix-system --- SYNPOSIS Dr. Abramowitz reviews recent data comparing outcomes of mechanical intervention versus lytic-based therapy, outlining how each approach fits into current practice. He underscores the critical role of IVUS in determining treatment endpoints, while noting the ongoing challenge of an absent standardized definition. The conversation also offers practical insights on procedural techniques and the evolving role of anticoagulation, emphasizing the importance of close collaboration and open communication with referring physicians. --- TIMESTAMPS 00:00 - Introduction00:45 - Overview of DVT Management02:50 - New Guidelines for DVT Treatment07:30 - Technical Endpoints in DVT Treatment13:26 - Clout Registry and Its Findings17:57 - Anticoagulation and DVT23:05 - Defining Acute DVT Management27:00 - Evolving Approaches to Acute DVT28:19 - Patient Experience and Quality of Life31:08 - Referring Providers and Data Impact37:01 - Single Session Treatments and Stenting41:07 - Chronic Venous Disease Management --- RESOURCES (ATTRACT) Weinberg I, Vedantham S, Salter A, et al. Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT Multicenter Randomized Trial. Vasc Med. 2019;24(5):442-451. doi:10.1177/1358863X19862043https://pubmed.ncbi.nlm.nih.gov/31354089/ (CLOUT) Shaikh A, Zybulewski A, Paulisin J, et al. Six-Month Outcomes of Mechanical Thrombectomy for Treating Deep Vein Thrombosis: Analysis from the 500-Patient CLOUT Registry. Cardiovasc Intervent Radiol. 2023;46(11):1571-1580. doi:10.1007/s00270-023-03509-8https://pubmed.ncbi.nlm.nih.gov/37580422/ (DEFIANCE) Abramowitz SD, Marko X, D'Souza D, et al. Rationale and design of the DEFIANCE study: A randomized controlled trial of mechanical thrombectomy versus anticoagulation alone for iliofemoral deep vein thrombosis. Am Heart J. 2025;281:92-102. doi:10.1016/j.ahj.2024.10.016https://pubmed.ncbi.nlm.nih.gov/39491572/

Join Andy Cumpstey and Kate Leslie in this broadcast from the ANESTHESIOLOGY® 2025 meeting. They welcome guests Stacie G. Deiner, an anesthesiologist, professor and vice-chair for research at Dartmouth Hitchcock Medical Center and Mark D. Neuman, anesthesiologist and Horatio C. Wood Professor of Anesthesiology at the Perelman School of Medicine at the University of Pennsylvania. We discuss the new ASA guidelines for older adults. The episode delves into the development, significant recommendations, and implementation of these guidelines, emphasizing the importance of preoperative evaluation and the choice of anesthesia technique. Mark and Stacie also highlight ongoing research and the future of perioperative care for older adults. This conversation underscores the role of shared decision-making and proactive health measures in improving surgical outcomes. The ASA guideline can be found here: https://www.asahq.org/standards-and-practice-parameters/practice-advisory-perioperative-care-of-older-adults-scheduled-for-inpatient-surgery The REGAIN study can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2113514

[Expertpanelen] Avsnitt 149 med Johan Strand, senior digital analyst och partner på byrån Ctrl Digital, om de senaste nyheterna och trenderna inom digital analys. Allt från hur GA4 förvandlas till en marknadsföringshubb med kostnadsimport av data från olika annonsplattformar, den enligt Johan största nyheten under GA4s livscykel. Till lanseringen av Analytics Advisor som gör det enklare att få svar och navigera i GA4. Du får dessutom höra om:  Nya funktioner för AI-analyser i BigQuery Apples nya taktik mot EU-regleringar Att hotet mot click-ID:n i iOS 26 lever EU-utredningen om cookies och samtycken Nya benchmarking-mätvärden i GA4 Om gästen Johan Strand är senior digital analyst och partner på Ctrl Digital, en av Sveriges ledande analytics-byråer. Han är otroligt vass på Google Analytics, BigQuery och att bygga datastrukturer som skapar affärsnytta. Som återkommande expert i poddens nyhetspanel delar Johan regelbundet sina analyser av de viktigaste förändringarna inom digital analys, spårning och datainsamling. Johan är också en av arrangörerna av MeasureCamp Malmö. Tidsstämplar [00:01:50] Största nyheten under GA4s livscykel. Genomgång av vad Johan anser är den största nyheten i GA4:s historia: möjligheten att importera kostnadsdata från plattformar som Meta och TikTok för att analysera direkt i verktyget. [00:14:23] Google Analytics får en AI-assistent. En genomgång av nya Google Analytics Advisor, en inbyggd AI-chatt som låter dig ställa frågor om din data och få snabba svar, förklaringar, grafer och länkar till rätt rapporter. [00:31:48] Apples hot mot klick-ID och spårning. En diskussion om Apples potentiella planer på att begränsa klick-ID:n i webbläsaren Safari och vilken enorm påverkan det skulle få på olika plattformars attributionsmodeller. [00:39:53] EU-utredningar kring cookies och samtycken. En pågående EU-utredning kan leda till enklare regler för samtycke och cookies, bland annat genom att hantera det på webbläsarnivå och tillåta anonym webbanalys utan aktivt medgivande. [00:51:03] Lightning round med andra analysnyheter. Kort om benchmarking i GA4, att Piwik Pro blir en betaltjänst, och vad Google Tag Gateway innebär för förstaparts-spårning. Länkar Johan Strand på LinkedInCtrl Digital (webbsida) Import data from external systems - Analytics Help (dokumentation)Analytics Advisor (Beta) - Analytics Help (dokumentation)[GA4] Analytics Insights - Analytics Help (dokumentation)Generative AI overview - BigQuery (dokumentation) Safari's New Tracking Prevention on Click IDs – Impact & Solutions - Ctrl Digital (artikel) Europe's cookie law messed up the internet. Brussels wants to fix it - Politico (artikel) Apple decries ‘intense lobbying,' says it may be forced to turn off App Tracking Transparency in Europe - 9to5mac (artikel) CNIL's New Guidelines and Recommendations On Cookie Consent - CookieYes (artikel) Cookies and the Data (Use and Access) Act 2025: what's changing and why it matters - Privacy Protect Group (artikel) Benchmarking support for unnormalized metrics - Google Analytics What's New (dokumentation) What is Google tag gateway for advertisers? - Google Tag Platform (dokumentation) Introducing Amplitude AI Visibility: The New Way to Monitor What AI Says About You - Amplitude (artikel) Introducing new pricing: More analytics value and privacy compliance as you grow - Piwik Pro (artikel)

This week we're joined by the brilliant Solaine Douglas, Nutritionist and women's health expert, for a deep dive into gestational diabetes — what it actually is, why it happens, and how women can support their bodies through it.We unpack the new reference ranges now being used in Australia, what they mean for testing, and why more women than ever are being diagnosed.Together, we chat about:✨ What gestational diabetes really means for you and your baby✨ Why blood sugar balance matters long before the test✨ The new Australian guidelines — explained simply✨ Nutrition strategies that actually help✨ Why diagnosis isn't a failure — and what to do nextWhether you're currently pregnant, planning to be, or supporting someone who is — this episode will leave you feeling informed, empowered, and far less anxious about the GTT.This episode is proudly sponsored by:✨ All Things Better – A carefully curated online wellness store bringing together the best in natural products, home essentials, and feel-good finds. They source brands that align with health, sustainability, and style, so you can shop knowing you're choosing better for yourself, your family, and the planet. ⁠Explore their range⁠.✨ This episode is brought to you by Chief Nutrition — the brand we're a little bit obsessed with. Their clean, high-protein snacks are made from real food, nothing fake or processed, and they actually taste amazing. Whether it's their beef bars, collagen bars, or liver capsules — we're huge fans. Use the code BARELYBALANCED for 20% off your order.

Who is getting what they want? and Dr. Tiffany Osborn on new guidelines and Medicare- h2 full 2230 Tue, 04 Nov 2025 22:34:58 +0000 EqdwEAjBr1IWBaNjPm9YnxbfWDTDR0dZ comedy,religion & spirituality,society & culture,news,government The Dave Glover Show comedy,religion & spirituality,society & culture,news,government Who is getting what they want? and Dr. Tiffany Osborn on new guidelines and Medicare- h2 The Dave Glover Show has been driving St. Louis home for over 20 years. Unafraid to discuss virtually any topic, you'll hear Dave and crew's unique perspective on current events, news and politics, and anything and everything in between. © 2025 Audacy, Inc. Comedy Religion & Spirituality Society & Culture News Government False http

From June 5, 2023: It's been about six months since the attorney general issued new guidelines on compulsory process to members of the press in criminal and national security investigations, and two officials of the Reporters Committee for Freedom of the Press—Bruce Brown and Gabe Rottman—wrote a detailed analysis of the document in two parts for Lawfare. Rottman joined Lawfare Editor-in-Chief Benjamin Wittes to go through the document carefully: the long history that led to it, the shifting policies that have gotten more restrictive over the years since the Supreme Court ruled in Branzburg v. Hayes, the ramp-up of leak investigations and reporter subpoenas in the Obama and Trump administrations, and the new policy that creates a red line policy against them under most (but not all) circumstances. They talked about the document, about why the Justice Department has forsworn a historic and upheld authority, and about what it means for reporters and criminal investigations going forward.To receive ad-free podcasts, become a Lawfare Material Supporter at www.patreon.com/lawfare. You can also support Lawfare by making a one-time donation at https://givebutter.com/lawfare-institute.Support this show http://supporter.acast.com/lawfare. Hosted on Acast. See acast.com/privacy for more information.

A popular social media platform is rolling out new guidelines aimed at protecting minors. FOX on Tech with the details of the changes and their implications for young users and parents. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Massey University has updated its retirement expenditure guidelines, which show how pensioners around the country are spending their money - and what you'd need to save to have that same lifestyle. Money correspondent Susan Edmunds spoke to Ingrid Hipkiss.

It's claimed new guidelines are restricting Clare Special Needs Assistants from helping children in the classroom. It comes as the Department of Education has also been requested to carry out a full review of additional needs school spaces in this county. A circular issued by the Department of Education in May states the role of the SNA is to support the care needs of a child and that responsibility for the overall progress of students lies with the classroom teacher. A recent report by the he National Council for Special Education has also indicated that SNAs should have no role in assisting children with behavioural difficulties, causing outcry in Clare. The local authority has now requested that Minister Helen McEntee calls for an urgent meeting with the NCSE to resolve the issues. Ennis Fianna Fáil Councillor and SNA, Antoinette Baker Bashua believes it's a glaring policy error.

The CDC updated its guidance on COVID and other vaccines. We break it down with Susan Hassig, an associate professor of epidemiology at Tulane.

The Australian Institute of Health and Welfare has declared that dementia is the leading cause of death among older Australians. - Ideklara ng Australian Institute of Health and Welfare na ang dementia ang nangungunang sanhi ng pagkamatay ng mga matatanda sa Australia.

A framework has been developed to track and improve the treatment options for dementia patients in aged care. The proposal come after the Australian Institute of Health and Welfare named dementia as the leading cause of death in Australia.

Dr. Refky Nicola speaks with Dr. Bari Dane, Associate Professor of Radiology at NYU, about the new SAR consensus recommendations for defining small bowel Crohn's disease strictures on CT and MR enterography. They explore updated imaging criteria, the challenges of distinguishing inflammation from fibrosis, and emerging roles for ultrasound and AI in diagnosis and treatment response. SAR Consensus Recommendations for Defining Small BowelCrohn Disease Strictures at CT and MR Enterography. Dane et al. Radiology 2025; 316(1):e243123.

Text Guidelines Coming to Google & Interview w/ Jyll Saskin Gales | Marketing O'Clock Episode 399This week on Marketing O'Clock: Google Ads introduces text guidelines, expands campaign total budget to Search, PMax, and Shopping, and sends mixed messages on the state of the open web.Thank you to our sponsor SYNUP - https://www.synup.com/enVisit us at - https://marketingoclock.com/

Drs. Petri and Fava discuss updated guidelines for the screening, treatment, and management of lupus nephritis.

Advocates are pressing New Jersey courts to enforce affordable housing requirements as towns fall short on construction. Meanwhile, pharmacies say demand for COVID shots is rising at the start of the school year, but new FDA guidelines are complicating access. Also, the New York Liberty have clinched a playoff spot despite losing 6 of their last 10 games. And WNYC's Liam Quigley reports on how Fire Island is grappling with climate change.

Banks and fintechs use Artificial Intelligence to detect fraud in credit scoring, but with new opportunities come new risks, including that of bias and accountability. The Reserve Bank of India recently released a report called Framework for Responsible and Ethical Enablement of AI (FREE-AI) to regulate the use of AI in the financial sector. The report has seven 'sutras' or guidelines and 26 recommendations to encourage innovation in this space. The report has seven 'sutras' or guidelines and 26 recommendations to encourage innovation in this space. Guest: Prof. Prasanna Tantri, Associate Professor of Finance and the Executive Director of the Centre for Analytical Finance at the Indian School of Business  Host: Nivedita V Edited by Jude Francis Weston Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Mehmet Oz, the high-ranking Trump administration official and television personality, is urging the Canadian government to step in, and save a B.C. herd of ostriches from being culled. The farm's owner lost a legal bid last week to stop the destruction of the birds, following an outbreak of avian influenza. Dr. Oz says the ostriches may hold clues to help control the virus.And: The prime minister continues his trip through eastern and central Europe, deepening international ties. In Poland, Mark Carney announced a new security partnership, and visited Canadian troops stationed there. The visit comes a day after Carney made a surprise stop in Kyiv, and said he was open to sending our soldiers into Ukraine, if the fighting with Russia ended.Also: A Canadian health taskforce delivers new recommendations on how to quit smoking. Spoiler alert — vaping is not recommended.Plus: Threatening wildfires in Nova Scotia lead to new evacuations, deadly strikes on a Gaza hospital, Trump's ongoing crime crackdown, and more.

The guidelines are in and the myths are out. In this episode of the BackTable Podcast, Dr. Suzette Sutherland hosts Dr. Melissa Kaufman and Dr. Giulia Ippolito to discuss the new 2025 AUA/SUFU guidelines on genitourinary syndrome of menopause (GSM). ---SYNPOSISThe doctors delve into what GSM is, its symptoms, and the new evidence-based clinical guidelines for screening, diagnosing, and treating this condition. The episode emphasizes shared decision-making, safe use of local low-dose vaginal estrogen, and addresses concerns related to hormone therapy and cancer risks. Additionally, the doctors cover non-hormonal interventions, the role of vaginal moisturizers and lubricants, and the use of vaginal lasers. The importance of follow-up and ongoing patient education is also highlighted. The conversation aims to equip clinicians with the knowledge to better manage GSM and improve patient outcomes.---TIMESTAMPS00:00 - Introduction 01:35 - Overview of the 2025 AUA/SUFU Guidelines02:27 - Guideline Development Process05:48 - Categories of Guidelines07:03 - Understanding GSM: Symptoms and Diagnosis10:28 - Patient Education and Shared Decision Making15:22 - Hormonal Interventions and Safety Concerns17:17 - Local Vaginal Estrogen: Recommendations and Usage23:12 - Compounded Estrogens and Alternative Therapies25:48 - Understanding Estrogen Dosage Forms26:11 - Introduction to DHEA and Its Benefits27:15 - Exploring Ospemifene as an Alternative28:05 - Guidelines for Treating GSM Symptoms30:11 - The Role of Vaginal Estrogen in UTI Prevention33:01 - Non-Hormonal Interventions for GSM35:39 - Laser Treatments for GSM39:59 - Addressing Cancer Risks with Vaginal Estrogen44:48 - Endometrial Surveillance and Follow-Up49:14 - Advocating for Vaginal Estrogen Use51:13 - Conclusion and Final Thoughts

The guidelines are in and the myths are out. In this episode of the BackTable Podcast, Dr. Suzette Sutherland hosts Dr. Melissa Kaufman and Dr. Giulia Ippolito to discuss the new 2025 AUA/SUFU guidelines on genitourinary syndrome of menopause (GSM). ---SYNPOSISThe doctors delve into what GSM is, its symptoms, and the new evidence-based clinical guidelines for screening, diagnosing, and treating this condition. The episode emphasizes shared decision-making, safe use of local low-dose vaginal estrogen, and addresses concerns related to hormone therapy and cancer risks. Additionally, the doctors cover non-hormonal interventions, the role of vaginal moisturizers and lubricants, and the use of vaginal lasers. The importance of follow-up and ongoing patient education is also highlighted. The conversation aims to equip clinicians with the knowledge to better manage GSM and improve patient outcomes.---TIMESTAMPS00:00 - Introduction 01:35 - Overview of the 2025 AUA/SUFU Guidelines02:27 - Guideline Development Process05:48 - Categories of Guidelines07:03 - Understanding GSM: Symptoms and Diagnosis10:28 - Patient Education and Shared Decision Making15:22 - Hormonal Interventions and Safety Concerns17:17 - Local Vaginal Estrogen: Recommendations and Usage23:12 - Compounded Estrogens and Alternative Therapies25:48 - Understanding Estrogen Dosage Forms26:11 - Introduction to DHEA and Its Benefits27:15 - Exploring Ospemifene as an Alternative28:05 - Guidelines for Treating GSM Symptoms30:11 - The Role of Vaginal Estrogen in UTI Prevention33:01 - Non-Hormonal Interventions for GSM35:39 - Laser Treatments for GSM39:59 - Addressing Cancer Risks with Vaginal Estrogen44:48 - Endometrial Surveillance and Follow-Up49:14 - Advocating for Vaginal Estrogen Use51:13 - Conclusion and Final Thoughts

Send us a text—This is an encore presentation of an episode previously published June 30—On this episode of the CMAJ Podcast, hosts Dr. Mojola Omole and Dr. Blair Bigham speak with two authors of the latest “Hypertension Canada guideline for the diagnosis and treatment of hypertension in adults in primary care”The discussion reflects a shared urgency: despite past successes, Canada's hypertension control rates are declining. The new guidelines aim to reverse this trend by simplifying diagnosis and treatment for frontline clinicians.Dr. Rémi Goupil, a nephrologist and clinician researcher at Sacré-Cœur Hospital in Montreal, and Dr. Greg Hundemer, a nephrologist and clinician scientist at The Ottawa Hospital, explain that the updated guideline is deliberately designed for primary care providers. They highlight key shifts: lowering the diagnostic threshold for hypertension to  ≥ 130/80 mm Hg, simplifying blood pressure targets, and emphasizing accurate, standardized measurement techniques both in clinic and at home. The guidelines were created with input from a majority-primary care committee—including family physicians, nurses, pharmacists, and patient partners—to ensure clinical applicability.Together, the panel outlines a streamlined nine-step treatment algorithm, emphasizing combination therapy as first-line pharmacologic management. They explain the evidence supporting ARB–thiazide combinations, discuss cost considerations for drug selection, and address adherence challenges. They also explore red flags for secondary hypertension and how the algorithm supports—but does not replace—clinical judgment.For physicians, this guideline offers a clear and practical roadmap: measure blood pressure correctly, aim for systolic pressure below 130 mm Hg, and use the simplified treatment sequence to improve adherence and outcomes. Designed to be easy to implement, the new approach aims to empower primary care providers to act with confidence.Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.You can find Blair and Mojola on X @BlairBigham and @DrmojolaomoleX (in English): @CMAJ X (en français): @JAMC FacebookInstagram: @CMAJ.ca The CMAJ Podcast is produced by PodCraft Productions

In this episode of Better Edge, Bruce K. Tan, MD, discusses the newest clinical practice guidelines for the surgical management of chronic rhinosinusitis (CRS). Dr. Tan covers how treatment paradigms have evolved over the past 15 years, from antibiotic-centric approaches to multifaceted strategies that recognize CRS as a complex inflammatory condition. He dives into the guidelines' recommendations on diagnoses, biologic therapies and multidisciplinary collaboration. Additionally, Dr. Tan shares insights on future directions for research and the promise of precision medicine in tailoring effective treatments for a range of patient profiles.

The Housing Minister has issued new guidelines on apartments, changing the minimum sizes, reducing the requirement for open spaces & removing requirements for communal spaces. To discuss this Tom Phillips, Town Planning Consultant /Adjunct Professor of Planning in UCD & Darragh Moriarty, Labour Party Councillor for Dublin South West Inner City.

Send us a textOn this episode of the CMAJ Podcast, hosts Dr. Mojola Omole and Dr. Blair Bigham speak with two authors of the latest “Hypertension Canada guideline for the diagnosis and treatment of hypertension in adults in primary care”The discussion reflects a shared urgency: despite past successes, Canada's hypertension control rates are declining. The new guidelines aim to reverse this trend by simplifying diagnosis and treatment for frontline clinicians.Dr. Rémi Goupil, a nephrologist and clinician researcher at Sacré-Cœur Hospital in Montreal, and Dr. Greg Hundemer, a nephrologist and clinician scientist at The Ottawa Hospital, explain that the updated guideline is deliberately designed for primary care providers. They highlight key shifts: lowering the diagnostic threshold for hypertension to  ≥ 130/80 mm Hg, simplifying blood pressure targets, and emphasizing accurate, standardized measurement techniques both in clinic and at home. The guidelines were created with input from a majority-primary care committee—including family physicians, nurses, pharmacists, and patient partners—to ensure clinical applicability.Together, the panel outlines a streamlined nine-step treatment algorithm, emphasizing combination therapy as first-line pharmacologic management. They explain the evidence supporting ARB–thiazide combinations, discuss cost considerations for drug selection, and address adherence challenges. They also explore red flags for secondary hypertension and how the algorithm supports—but does not replace—clinical judgment.For physicians, this guideline offers a clear and practical roadmap: measure blood pressure correctly, aim for systolic pressure below 130 mm Hg, and use the simplified treatment sequence to improve adherence and outcomes. Designed to be easy to implement, the new approach aims to empower primary care providers to act with confidence.Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.You can find Blair and Mojola on X @BlairBigham and @DrmojolaomoleX (in English): @CMAJ X (en français): @JAMC FacebookInstagram: @CMAJ.ca The CMAJ Podcast is produced by PodCraft Productions

Welcome to the Hughes Hubbard Anti-Corruption & Internal Investigations Practice Group's podcast, All Things Investigation. In this episode of ‘All Things Investigations,' host Tom Fox is joined by Mike DeBernardis to discuss the recent guidelines released by Deputy Attorney General Todd Blanche on the enforcement of the Foreign Corrupt Practices Act (FCPA). They dissect the new memorandum, its implications for corporate investigations, and the focus on eliminating cartels and transnational criminal organizations. The conversation also delves into topics such as competitive advantage, the role of national security in FCPA enforcement, and the strategic implications for companies. The episode concludes with insights on how companies and their legal counsel should navigate these updated guidelines and prepare for a more expedited and focused investigation process. Key highlights: Overview of New FCPA Guidelines Focus on Competitive Advantage Prosecutorial Considerations National Security and Strategic Business Prioritizing Serious Misconduct Advising Clients on FCPA Compliance Resources: Mike DeBernardis Hughes Hubbard & Reed website HHR Client Alert: DOJ Ends FCPA Enforcement Pause

  Utah has released new guidelines on screen time in young children and the impacts that can have on their development. We have the Director of Utah Office of Families, Aimee Winder Newton on the show to discuss these new guidelines and the screentime recommendations on children under six. 

The Missing Persons Identification Act requires law enforcement in Illinois to take a report immediately when they are notified of a missing person and enter it into the Law Enforcement Agencies Data System, called 'LEADS'.

The Missing Persons Identification Act requires law enforcement in Illinois to take a report immediately when they are notified of a missing person and enter it into the Law Enforcement Agencies Data System, called 'LEADS'.

The Missing Persons Identification Act requires law enforcement in Illinois to take a report immediately when they are notified of a missing person and enter it into the Law Enforcement Agencies Data System, called 'LEADS'.

ABC's Jim Ryan tells us about the new guidance.

Vitamin D recommendations in 1941 began this debate. Over the years, updated guidelines have continued to spark controversy and debate in the field of vitamin D research.In this episode of Daily Value, we look at the recent “Vitamin D-ilemma” reinvigorated by the Endocrine Society's updated 2024 guidelines. These new recommendations have dialed back routine testing and supplementation targets, igniting pushback from leading researchers who argue we might be overlooking significant health benefits (including reduced risks for 8 out of the top 10 leading causes of death). Join us as we Look at the evolving science behind vitamin D, why randomized trials and observational studies seem to tell different stories, and how you can practically navigate these conflicting recommendations to optimize your own health.00:00 Introduction: The Vitamin D Controversy01:00 Historical Guidelines and Shifts01:54 The 2011 Guidelines and Their Impact03:57 The 2024 Update: A New Debate06:13 Understanding Vitamin D's Role in the Body07:29 Clinical Trials vs. Observational Studies09:13 Health Benefits of Higher Vitamin D Levels11:58 Challenges in Vitamin D Research15:56 Practical Recommendations for Optimal Vitamin D19:32 Conclusion: Striving for Optimal HealthPMID: 39861407PMID: 38828961PMID: 37004709PMID: 30992519Support the show

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZKX865. CME/MOC/CPE/AAPA/IPCE credit will be available until May 1, 2026.Taking a Step Forward in HCM Precision Medicine: Aligning Clinical and Managed Care Approaches With New Guidelines, Long-Term Evidence, and Real-World Experience In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZKX865. CME/MOC/CPE/AAPA/IPCE credit will be available until May 1, 2026.Taking a Step Forward in HCM Precision Medicine: Aligning Clinical and Managed Care Approaches With New Guidelines, Long-Term Evidence, and Real-World Experience In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZKX865. CME/MOC/CPE/AAPA/IPCE credit will be available until May 1, 2026.Taking a Step Forward in HCM Precision Medicine: Aligning Clinical and Managed Care Approaches With New Guidelines, Long-Term Evidence, and Real-World Experience In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZKX865. CME/MOC/CPE/AAPA/IPCE credit will be available until May 1, 2026.Taking a Step Forward in HCM Precision Medicine: Aligning Clinical and Managed Care Approaches With New Guidelines, Long-Term Evidence, and Real-World Experience In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

Contributor: Aaron Lessen, MD Educational Pearls: What is a Rescue Inhaler? A rescue inhaler is a medication for people with asthma to quickly reverse the symptoms of an asthma attack. Historically albuterol (Short Acting Beta Agonist (SABA)) monotherapy has been the mainstay rescue inhaler. This is because albuterol works fast and is relatively cheap. What are Combination Rescue Inhalers? Combination rescue inhalers contain a fast-acting bronchodilator as well as an inhaled corticosteroid (ICS) The steroid helps to reduce some of the chronic airway inflammation that is worsening the asthma attack and can help to prevent future attacks Examples include budesonide-formoterol and albuterol-budesonide Global Initiative for Asthma (GINA), states that combination therapy is now the preferred reliever for adults and adolescents with mild asthma What are the drawbacks of Combination Rescue Inhalers? These inhalers are generally more expensive than just using a SABA inhaler which can be a barrier for some people Improper use can also lead to conditions like thrush due to the addition of the steroid References Krings JG, Beasley R. The Role of ICS-Containing Rescue Therapy Versus SABA Alone in Asthma Management Today. J Allergy Clin Immunol Pract. 2024 Apr;12(4):870-879. doi: 10.1016/j.jaip.2024.01.011. Epub 2024 Jan 17. PMID: 38237858; PMCID: PMC10999356. Papi A, Chipps BE, Beasley R, Panettieri RA Jr, Israel E, Cooper M, Dunsire L, Jeynes-Ellis A, Johnsson E, Rees R, Cappelletti C, Albers FC. Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. N Engl J Med. 2022 Jun 2;386(22):2071-2083. doi: 10.1056/NEJMoa2203163. Epub 2022 May 15. PMID: 35569035. Summarized by Jeffrey Olson, MS3 | Edited by Jorge Chalit, OMS3 Donate: https://emergencymedicalminute.org/donate/  

Confused about what to tell parents when they ask, “Is oat milk okay?” or “How much juice is too much?” You're not alone—it's confusing.In this episode, I'm joined by Megan Lott, MPH, RDN, Deputy Director of Healthy Eating Research. Megan walks us through the first-ever unified beverage guidelines for kids—developed by leading organizations like the AAP, AND, and AHA.We cover what to encourage, what to limit, and what to avoid based on the latest research.What to Drink:Daily water intake by age (and why thirst isn't a reliable guide)When and how much milk is recommended—and which plant-based alternatives come closeWhat to Limit:Portion limits for 100% juice and flavored milkWhy sports drinks aren't necessary for most kidsHow to help families cut back without resistanceWhat to Avoid:The surprising oral health danger of seltzersThe latest on non-nutritive sweetenersThe impact of caffeine on sleep, blood pressure, and mental health in kidsWhether you're in pediatrics, family med, or are a parent, this conversation will give you clear guidance on what to drink!Resources:Beverage Recommendations Provider ToolkitAges 5-18 Beverage RecommendationsEpisode 71 | Sports Nutrition Hot Topics: Sugar, Sports Drinks and Fueling for PerformanceEpisode 65 | Does Coffee Stunt Growth?Any Questions? Send Me a MessageSupport the showConnect with Colleen:InstagramLinkedInSign up for my FREE Newsletter - Nutrition hot-topics delivered to your inbox each week. Support the show!If you love the show and want to help me make it even better, buy me a coffee to help me keep going! ☕️Disclaimer: This podcast is a collection of ideas, strategies, and opinions of the author(s). Its goal is to provide useful information on each of the topics shared within. It is not intended to provide medical, health, or professional consultation or to diagnosis-specific weight or feeding challenges. The author(s) advises the reader to always consult with appropriate health, medical, and professional consultants for support for individual children and family situations. The author(s) do not take responsibility for the personal or other risks, loss, or liability incurred as a direct or indirect consequence of the application or use of information provided. All opinions stated in this podcast are my own and do not reflect the opinions of my employer.

Welcome back! Today we will be discussing Metformin and some of the recent guidelines published in the journal the Schizophrenia Bulletin. (Carolan et. al 2024).

What to know about new guidelines on screen time for teens, how to implement healthy screen habits Please Subscribe + Rate & Review KMJ’s Afternoon Drive with Philip Teresi & E. Curtis Johnson wherever you listen! --- KMJ’s Afternoon Drive with Philip Teresi & E. Curtis Johnson is available on the KMJNOW app, Apple Podcasts, Spotify, Amazon Music or wherever else you listen. --- Philip Teresi & E. Curtis Johnson – KMJ’s Afternoon Drive Weekdays 2-6 PM Pacific on News/Talk 580 & 105.9 KMJ DriveKMJ.com | Podcast | Facebook | X | Instagram --- Everything KMJ: kmjnow.com | Streaming | Podcasts | Facebook | X | Instagram See omnystudio.com/listener for privacy information.

What to know about new guidelines on screen time for teens, how to implement healthy screen habits Please Subscribe + Rate & Review KMJ’s Afternoon Drive with Philip Teresi & E. Curtis Johnson wherever you listen! --- KMJ’s Afternoon Drive with Philip Teresi & E. Curtis Johnson is available on the KMJNOW app, Apple Podcasts, Spotify, Amazon Music or wherever else you listen. --- Philip Teresi & E. Curtis Johnson – KMJ’s Afternoon Drive Weekdays 2-6 PM Pacific on News/Talk 580 & 105.9 KMJ DriveKMJ.com | Podcast | Facebook | X | Instagram --- Everything KMJ: kmjnow.com | Streaming | Podcasts | Facebook | X | Instagram See omnystudio.com/listener for privacy information.

This week on Hafta, Newslaundry's Abhinandan Sekhri, Manisha Pande and Anand Vardhan are joined by The Caravan's Hartosh Singh Bal and Delhi University professor Tanvir Aeijaz. The panel begins the show by discussing Narendra Modi's meeting with Donald Trump which Manisha terms “a test of statecraft” for Modi. The discussion then moves to the Delhi election result, which saw the BJP returning to power after 27 years. “This is a new BJP. It has gained strength since the 2024 Lok Sabha elections,” says Hartosh. “...These elections were not fought on Modi's back. The party now has organisational strength. Even if Modi falls to the wayside, it does not make a difference to the BJP.” As the panel discusses the AAP and Congress's performance, Abhinandan says, “One thing BJP has pulled off well is that they won Delhi without a [chief ministerial] face.”Tanvir talks about the controversy surrounding the new UGC draft guidelines that give state governors a prominent role in selecting vice-chancellors. “This regulation comes in the backdrop of the idea that we need to have one curriculum, one education system across the country,” he says. “But education is a concurrent subject…everything in a monastic form creates a problem for federalism.”This and a lot more. Tune in!Hafta letters: Economies and ‘police states', the question of ads, courts and paroleWe have a page for subscribers to send letters to our shows. If you want to write to Hafta, click here. Check out the Newslaundry store and flaunt your love for independent media. Download the Newslaundry app. Contribute to our latest NL Sena here.Watch the full video: https://youtu.be/9Az11BtCKQ8Timecodes00:00:00 - Introductions and announcements00:04:57 - Headlines00:11:48 - Modi in America00:18:20 - Delhi elections 00:45:13 - Manipur developments00:51:20 - UGC guidelines 01:22:16 - Tanvir's recommendation01:29:55 - Hartosh's recommendation 01:33:17 - Letters01:46:01 - Recommendations Check out previous Hafta recommendations, references, songs and letters Produced and recorded by Priyali Dhingra and Ashish Anand.This episode is outside of the paywall, just for the week and just for you. Before it goes back behind the paywall, why not subscribe? Get brand-new episodes of all our podcasts every week, while also doing your bit to support independent media. Click here to subscribe. Hosted on Acast. See acast.com/privacy for more information.

A Clinician's guide to TMD Management Walkthrough of the latest TMD Guidelines with the authors! What's the right approach when a patient presents with both acute and chronic painful jaw symptoms? How can the latest RCS guidelines simplify your diagnosis and treatment process? In this episode, Professor Justin Durham and Mrs. Emma Beecroft join Jaz to unpack the latest Royal College of Surgeons TMD guidelines designed specifically to help GDPs navigate these tricky cases. Together, they explore practical strategies for managing TMD, breaking down the step-by-step flowchart that makes handling these cases less intimidating. From understanding the key principles to applying them in everyday practice, this episode will help you feel more confident in delivering better patient care for TMD. https://youtu.be/R0NaBJr5g5E Watch PDP213 on Youtube Protrusive Dental Pearl: Important takeaway: Download the New TMD Guidelines  The folder includes: A patient version of the guidelines A dentist version of the guidelines The full guidelines document Video of delivering an equilibrated soft bite guard using heat technique Key Takeaways: The guidelines for TMD are designed to simplify diagnosis and treatment. Self-management is crucial for TMD patients and can lead to better outcomes. Understanding the difference between muscle and joint pain is essential in TMD management. Early intervention in TMD can lead to significant improvements for patients. The importance of patient-centered care in managing TMD effectively. TMD is a common issue that requires a collaborative approach among dental professionals. The role of pain management in TMD is about improving quality of life, not just curing the condition. Continuous education and training are vital for dental professionals dealing with TMD. Understanding the pathogenesis of TMD is crucial for effective treatment. Stabilization splints can provide relief but should be used judiciously. Effective communication can significantly impact patient pain experiences. Tailoring treatment to individual patient needs is vital. Highlights for this episode: 00:48 Protrusive Dental Pearl 05:20 Introducing the Guests: Prof. Justin Durham and Mrs. Emma Beecroft 13:05 Stigma and Complexity of TMD in Dentistry 17:01 Challenges of Navigating TMD Treatment Perspectives 22:07 Diagnosing TMD: Tools and Techniques 27:09 Simplified Approach to TMD Examination 30:54 Muscle Palpation Pressure  32:20 Acute Limited Opening: Muscle vs. Joint Origin 40:20 Diazepam for Acute Myogenous TMD 54:58 Debating Soft vs. Stabilization Splints 57:17 Patient-Centered TMD Management 01:09:28 Conclusion and Resources This episode is eligible for 1 CE credit via the quiz on Protrusive Guidance.  This episode meets GDC Outcomes B and C. AGD Subject Code: 200 OROFACIAL PAIN (Diagnosis and treatment) Dentists will be able to - Explore the varied approaches to TMD care and how to align them with evidence-based practices. Emphasize the importance of self-management strategies and their role in improving patient outcomes. Advocate for a patient-centered approach, focusing on listening, communication, and individualized care plans. If you loved this episode, be sure to check out this episode: TMD Full Exam with ‘The TMJ Doc' Dr Priya Mistry – PDP064

The government has released new guidelines for the safe use of AI in the public sector. Digitising Government Minister Judith Collins spoke to Ingrid Hipkiss.

The Vatican has approved new guidelines from the Italian Bishops' Conference, allowing gay men to enter seminaries if they commit to celibacy, as expected of all seminarians regardless of sexual orientation. This week on “Inside the Vatican,” Colleen Dulle and Gerard O'Connell discuss whether this signals a shift in admissions policy and the potential implications for seminarians worldwide. They also cover Pope Francis's annual address to diplomats accredited to the Holy See, where he called for a “diplomacy of hope.” Later, Gerry shares highlights from his interview with Filipino Cardinal Pablo Virgilio “Ambo” David, who faced death threats for opposing former President Rodrigo Duterte's war on drugs. The cardinal also observes what he sees as contrasting approaches to evangelization between Pope Francis, who calls the church to go outside its doors and seek those on the peripheries, and Pope Benedict, who stressed opening the church's doors to welcome people in. Please support this podcast by becoming a digital subscriber to America Media. Learn more about your ad choices. Visit megaphone.fm/adchoices

This week, John and Elliot discuss actions by the US Treasury against Hamas and fentanyl traffickers, new regulations from CFIUS to enhance enforcement of limitations on foreign investment in the US to protect national security, new guidelines from the European Banking Authority to streamline and standardize AML rules, observance of International Fraud Awareness Week, and several other items impacting the financial crime prevention community.

“CDK4/6 inhibition is considered to be a milestone in the realm of targeted breast cancer therapy. The combination of CDK4/6 inhibitors with the endocrine therapy has really emerged as the foremost therapeutic modality for patients diagnosed with hormone receptor–positive, HER2-negative, advanced breast cancer,” ONS member Teresa Knoop, MSN, RN, AOCN®-emeritus, independent nurse consultant in Nashville, TN, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during the latest episode in our series about anticancer drug classes. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by October 18, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to CDK inhibitors. Episode Notes  Complete this evaluation for free NCPD.  Oncology Nursing Podcast™ episodes: Pharmacology 101 series Episode 329: Pharmacology 101: BRAF Inhibitors Episode 313: Cancer Symptom Management Basics: Other Pulmonary Complications Episode 295: Cancer Symptom Management Basics: Pulmonary Embolism, Pneumonitis, and Pleural Effusion Episode 80: Patients Need Checkpoint Inhibitor Education Episode 5: New Guidelines for Managing Immunotherapy-Related Adverse Events ONS Voice articles: Combination CDK4/6 and Fulvestrant Has Survival Benefits in Late-Stage Breast Cancer FDA Approves Inavolisib With Palbociclib and Fulvestrant for Endocrine-Resistant, PIK3CA-Variant, HR-Positive, HER2-Negative, Advanced Breast Cancer FDA Approves Ribociclib With an Aromatase Inhibitor and Ribociclib and Letrozole Co-Pack for Early High-Risk Breast Cancer FDA Expands Early Breast Cancer Indication for Abemaciclib With Endocrine Therapy FDA Warns of Rare Lung Inflammation With Certain CDK4/6 Inhibitors Manage Immunotherapy-Related Diarrhea and Colitis Oncology Drug Reference Sheet: Ribociclib The Case of the CTCAE Assessment for CDK4/6 Adverse Events ONS book: Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) Clinical Journal of Oncology Nursing article: Targeted Therapies: Treatment Options for Patients With Metastatic Breast Cancer ONS Symptom Intervention: Prevention of Infection: General  ONS Breast Cancer Learning Library ONS CDK4/6 Administration Checklist ONS Oral Anticancer Medication Toolkit  Breastcancer.org Susan G. Komen: CDK4/6 Inhibitors Ibrance® (palbociclib) patient site Kisqali® (ribociclib) patient site Verzenio® (abemaciclib) patient site To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an Oncology Nursing Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Common toxicity among this class of agents are things like nausea/vomiting, diarrhea, fatigue. All three are associated with low white blood cell counts, which we know as neutropenia, which can cause an increased risk of infection.” TS 10:46 “All three of these CDK4/6 inhibitors are pills taken by mouth, and in most cases they're all given along with endocrine therapy treatments. So, patients will be taking more than one drug. Teach patients how they will take their medication. And the frequency among the three drugs may vary.” TS 13:33 “Patients and caregivers need to know the time of day to take the pills, whether they need to be taken with or without food, or what to do if they miss a dose. We need to help them with a system for organizing the medications. They may find it helpful to use a pill organizer or set reminders on their smartphone, their smartwatch, their computer.” TS 14:29  “Pharmacy and nursing, in my experience, collaborate greatly by determining those drug–drug and drug–food interactions. It is so crucial in determining those interactions and educating our patients because we have to remind patients at each appointment and review these drugs and foods and other things they may be taking, at each appointment. And that often can be done by either pharmacists or nurses or both in collaboration.” TS 23:29 “This class of drug is generally well-tolerated, and I do want nurses to know that that we can help patients with these side effects. And they are generally well-tolerated with appropriate management.” TS 30:55 

In the first hour of "Connections with Evan Dawson" on Tuesday, October 1, 2024, we speak with a local doctor about the new guidelines for breast cancer screening, hear a local survivor's breast cancer story and explore what community resources are available to patients dealing with the disease.

The U.S. Preventive Services Task Force has updated its recommendations for breast cancer screening once again. The recommendations now stipulate that women and people assigned female at birth should begin getting mammograms at age 40, and continue every other year until age 74. The previous guidelines recommended beginning screening at age 50. These guidelines carry a lot of weight because they determine if mammography will be considered preventive care by health insurance and therefore covered at no cost to the patient.Why have the guidelines changed? And how are these decisions made in the first place? To answer those questions and more Ira Flatow talks with Dr. Janie Lee, director of breast imaging at the Fred Hutchinson Cancer Center and professor of radiology at the University of Washington School of Medicine.Transcript for this segment will be available the week after the show airs on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.